Wittrup M, Pildal J, Rasmussen AK, Skov BG, Petersen J. 2003 Mandrup-Poulsen TR. Systemic and local allergy to human insulin. Ugeskr Laeger. 19 165(21):2207–8
Wonders J, Eekhoff EM, Heine R, Bruynzeel DP, Rustemeyer T. Insulin allergy: background, diagnosis and treatment [in Dutch]. Ned Tijdschr Geneeskd. 2005;149:2783–8.
Petersen KG, Khalaf A, Zeisel HJ, Stryjek-Kaminska D, Kerp L. IgE antibodies to human growth hormone prior to and during treatment. Acta Endocrinol. 1989;121:501–4.
Khalaf AN, Kerp L, Schliebs B, Jägle M. Petersen KG Natural occurrence of IgE antibodies to peptide hormones in man. Eur J Clin Invest. 1989;19(5):464–5.
Article PubMed CAS Google Scholar
Junprasert J, Javier FC 3rd, Rodriguez JA, Moore C, Sorensen RU. Successful intravenous desensitization of growth hormone hypersensitivity. J Pediatr Endocrinol Metab. 1997;10:223–6.
Article PubMed CAS Google Scholar
Walker SB, Weiss ME, Tattoni DS. Systemic reaction to human growth hormone treated with acute desensitization. Pediatrics. 1992;90(1 Pt 1):108–9.
Article PubMed CAS Google Scholar
Albertsson-Wikland K. Clinical trial with authentic recombinant somatropin in Sweden and Finland. Acta Paediatr Scand Suppl. 1987;331:28–34.
Article PubMed CAS Google Scholar
Forte WC, Kochi C, Faria CD, Calliari LE, Monte O, Longui CA. Growth hormone therapy and hypersensitivity type III reaction: a contraindication for desensitization. Arq Bras Endocrinol Metabol. 2011;55:78–80.
Soares MQ, Mendonca EF. Lichen planus-like drug reaction associated with recombinant human growth hormone therapy in a child patient with Turner syndrome. Dermatol Online J. 2016;22:14.
Oono T, Arata J. Childhood lichen planus in a patient receiving growth hormone for dwarfism. Dermatology. 1996;192:87–8.
Article PubMed CAS Google Scholar
Acikgoz G, Ozmen I, Tunca M, Akar A, Arca E, Saifurrahman S. Psoriasis induced by growth hormone therapy in a patient with Turner’s syndrome. Int J Dermatol. 2015;54:e132–5.
Pirgon O, Atabek ME, Sert A. Psoriasis following growth hormone therapy in a child. Ann Pharmacother. 2007;41:157–60.
Article PubMed CAS Google Scholar
Maghnie M, Borroni G, Larizza D, Lorini R, Girani MA, Rabbiosi G, Severi F. Relapsing eruptive psoriasis and immunological changes triggered by growth hormone therapy in a growth hormone-deficient girl. Dermatologica. 1990;181:139–41.
Article PubMed CAS Google Scholar
Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, Rouzaire P, Ebo DG, Sabato V, Sanz M, Pecaric-Petkovic T, Patil SU, Hausmann OV, Shreffler WG, Korosec P, Knol EF. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. 2015;70:1393–405.
Article PubMed CAS Google Scholar
Mayorga C, Çelik GE, Pascal M, Hoffmann HJ, Eberlein B, Torres MJ, Brockow K, Garvey LH, Barbaud A, Madrigal-Burgaleta R, Caubet JC, Ebo DG. Flow-based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper. Allergy. 2024;79(3):580–600
Romano A, Atanaskovic-Markovic M, Barbaud A, Bircher AJ, Brockow K, Caubet JC, Celik G, Cernadas J, Chiriac AM, Demoly P, Garvey LH, Mayorga C, Nakonechna A, Whitaker P, Torres MJ. Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper. Allergy. 2020;75(6):1300–2131.
Bavbek S, Pagani M, Alvarez-Cuesta E, Castells M, Dursun AB, Hamadi S, Madrigal-Burgaleta R, Sanchez-Sanchez S, Vultaggio A. Hypersensitivity reactions to biologicals: An EAACI position paper. Allergy. 2022;77(1):39–54.
Atanaskovic-Markovic M, Gomes E, Cernadas JR, du Toit G, Kidon M, Kuyucu S, Mori F, Ponvert C, Terreehorst I. Caubet JC Diagnosis and management of drug-induced anaphylaxis in children: an EAACI position paper. Pediatr Allergy Immunol. 2019;30(3):269–76.
Carbonell A, Escudero AI, Miralles JC, González A, Navarro C, Cardona P, Jimeno L, Pineda F. Anaphylaxis due to poloxamer 238. J Investig Allergol Clin Immunol. 2018;28(6):419–20.
Article PubMed CAS Google Scholar
Ionova Y, Wilson L. Biologic excipients: importance of clinical awareness of inactive ingredients. PLoS One. 2020 25;15(6):e0235076
Bruusgaard-Mouritsen MA, Nasser S, Garvey LH, Krantz MS, Stone CA Jr. Anaphylaxis to excipients in current clinical practice: evaluation and management. Immunol Allergy Clin North Am. 2022;42(2):239–67.
Article PubMed PubMed Central Google Scholar
Kwek JW, Chakraborty S, Kuan KC, Yeo WC, Yin H, Liu CK, Guo L, Zidar J, Li C, Lim FCH. Interactions between poloxamer, PEOx-PPOy-PEOx, and non-ionic surfactant, sucrose monolaurate: a study on potential allergenic effect using model phospholipid membrane. Colloids Surf B Biointerfaces. 2022;209(Pt 1)
Venturini Díaz M, Vidal Oribe I, D’Elia Torrence D, Hernández Alfonso P, Alarcón GE. New challenges in drug allergy: the resurgence of excipients. Curr Treat Options Allergy. 2022;9(3):273–91.
Article PubMed PubMed Central Google Scholar
Chirumbolo S, Vella A, Ortolani R, De Gironcoli M, Solero P, Tridente G, Bellavite P. Differential response of human basophil activation markers: a multi-parameter flow cytometry approach. Clin Mol Allergy. 2008;6:12.
Article PubMed PubMed Central Google Scholar
Céspedes JA, Fernández-Santamaría R, Ariza A, Bogas G, Doña I, Rondón C, Salas M, Labella M, Frecha C, Mayorga C, Torres MJ, Fernández TD. Diagnosis of immediate reactions to amoxicillin: comparison of basophil activation markers CD63 and CD203c in a prospective study. Allergy. 2023;78(10):2745–55.
Restivo V, Candore G, Barrale M, Caravello E, Graziano G, Onida R, Raineri M, Tiralongo S, Brusca I. Allergy to polyethilenglicole of anti-SARS CoV2 vaccine recipient: a case report of young adult recipient and the management of future exposure to SARS-CoV2. Vaccines (Basel). 2021;9(5):412.
Comments (0)